Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ClouDr GroupFRA:H3L 48 Forward Dividend Yield % is 0.00% as of Aug. 27, 2026. GuruFocus rates FRA:H3L with a GF Score™ of 48/100 and a GF Value™ of €0.08. The stock has 9 warning signs investors should review. Among 69 Medical Distribution companies, ClouDr Group ranks worse than 1449273.91% on this metric.
As of today (2026-08-27), the Forward Annual Dividend Yield of ClouDr Group is 0.00%.
As of today (2026-08-27), the Trailing Annual Dividend Yield of ClouDr Group is 0.00%.
FRA:H3L's Forward Dividend Yield % is not ranked *
in the Medical Distribution industry.
Industry Median: 2.9 * Ranked among companies with meaningful Forward Dividend Yield % only.
ClouDr Group (FRA:H3L) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
ClouDr Group Forward Dividend Yield % Related Terms
FRA:H3L vs MCK, COR, CAH: Forward Dividend Yield % Comparison
For the Medical Distribution subindustry, ClouDr Group's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ClouDr Group Forward Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ClouDr Group's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where ClouDr Group's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
ClouDr Group (FRA:H3L) has a Forward Dividend Yield % of 0.00% as of Aug. 27, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on ClouDr Group and its competitors. According to the industry distribution chart, ClouDr Group ranks #999999 out of 69 companies in the Medical Distribution industry.
Is ClouDr Group's Forward Dividend Yield % too high?
ClouDr Group's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, ClouDr Group ranks #999999 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, ClouDr Group has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does ClouDr Group's Forward Dividend Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ClouDr Group ranks #999999 out of 69 companies for Forward Dividend Yield %. This places ClouDr Group in the lower half of its industry. The industry median Forward Dividend Yield % is 2.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Distribution company?
The median Forward Dividend Yield % among Medical Distribution companies is 2.90, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on ClouDr Group and its competitors. For the Medical Distribution industry, the median Forward Dividend Yield % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ClouDr Group's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ClouDr Group stock overvalued right now?
ClouDr Group (FRA:H3L) has a current Forward Dividend Yield % of 0.00%. The stock's GF Value™ is €0.08, compared to a current price of €0.05 — trading 36.9% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. ClouDr Group's overall GF Score™ is 48/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For ClouDr Group (FRA:H3L), the current Forward Dividend Yield % is 0.00% as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ClouDr Group (FRA:H3L) Overvalued in 2026?
Based on GuruFocus' analysis, ClouDr Group stock appears to be undervalued.
The current stock price of €0.05 is trading 36.9% below its estimated GF Value™ of €0.08.
Key valuation signals for FRA:H3L:
Forward Dividend Yield %: 0.00%
GF Value™: €0.08 vs. price of €0.05 (36.9% below fair value)
No single metric tells the full story. See the FRA:H3L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. The company's in-hospital solution consists of sales of medical devices, consumables, and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies, and the out-of-hospital solution connects doctors and patients, and provides high-quality and trustworthy medical services through the AI vertical model ClouD GPT. The company generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.
48GF Score
Get the complete analysis for FRA:H3L
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:H3L has been successfully added to your 
